Page last updated: 2024-08-21

pyrazines and tas-116

pyrazines has been researched along with tas-116 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Anderson, KC; Chauhan, D; Cirstea, D; Cottini, F; Gorgun, G; Hideshima, T; Jakubikova, J; Kikuchi, S; Mimura, N; Minami, J; Munshi, NC; Ohguchi, H; Richardson, PG; Suzuki, R; Tai, YT; Utsugi, T; Yoshida, Y	1

Other Studies

1 other study(ies) available for pyrazines and tas-116

Article	Year
Anti-tumor activities of selective HSP90α/β inhibitor, TAS-116, in combination with bortezomib in multiple myeloma. Leukemia, 2015, Volume: 29, Issue:2 Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzamides; Boronic Acids; Bortezomib; Cell Line; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Screening Assays, Antitumor; HSP90 Heat-Shock Proteins; Humans; Mice; Mice, SCID; Monomeric GTP-Binding Proteins; Multiple Myeloma; Mutation; Neoplasm Transplantation; Pyrazines; Pyrazoles; Retinal Pigment Epithelium	2015

Article

Year

Anti-tumor activities of selective HSP90α/β inhibitor, TAS-116, in combination with bortezomib in multiple myeloma.

Leukemia, 2015, Volume: 29, Issue:2

Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzamides; Boronic Acids; Bortezomib; Cell Line; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Screening Assays, Antitumor; HSP90 Heat-Shock Proteins; Humans; Mice; Mice, SCID; Monomeric GTP-Binding Proteins; Multiple Myeloma; Mutation; Neoplasm Transplantation; Pyrazines; Pyrazoles; Retinal Pigment Epithelium

2015